Agilent has announced that it will acquire Genohm, a developer of highly differentiated, on-premise and cloud-based software solutions for laboratory management
Certara, a provider of model-informed drug development and regulatory science, has announced that it has acquired Analytica Laser
BC Platforms, a provider of genomic data management and analytics has announced the appointment of Richard Kivel as its Chairman
Agilent Technologies has announced that it has signed an agreement to acquire Lasergen
ID Genomics (IDG), a Seattle-based, developer of rapid point-of-care diagnostics, has announced the discovery of a nationwide rise in the levels of a drug-resistant ‘superbug’ - Escherichia coli strain ST1193
Robert Roe reports on the Paperless Lab Academy event on the potential impact of disruptive technologies such as blockchain and IoT in the laboratory
At The Pistoia Alliance’s annual EU member conference in London, president of the Pistoia Alliance, Dr Steve Arlington, urged stakeholders to come together to help technology continue to drive change in the industry and to amplify R&D budgets
A web-based tool to promote the sharing of research reagents and information can help tackle the crisis in reproducibility in life-science research, argues Isobel Atkin.
Certara, the global leader in model-informed drug development and regulatory science, today announced the launch of its Quantitative Systems Pharmacology (QSP) Immuno-oncology Simulator Consortium
Citoxlab Group, which offers a range of preclinical and specialty services, has announced it attends to acquire Solvo Biotechnology
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
